Michael Celano
2016 - Recro Pharma
In 2016, Michael Celano earned a total compensation of $1.2M as Chief Financial Officer at Recro Pharma.
Compensation breakdown
| Bonus | $172,500 |
|---|---|
| Option Awards | $823,200 |
| Salary | $164,538 |
| Other | $6,538 |
| Total | $1,166,766 |
Celano received $823.2K in option awards, accounting for 71% of the total pay in 2016.
Celano also received $172.5K in bonus, $164.5K in salary and $6.5K in other compensation.
Rankings
In 2016, Michael Celano's compensation ranked 7,486th out of 14,075 executives tracked by ExecPay. In other words, Celano earned more than 46.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,486 out of 14,075 | 47th |
Division Manufacturing | 2,832 out of 5,486 | 48th |
Major group Chemicals And Allied Products | 934 out of 1,900 | 51st |
Industry group Drugs | 723 out of 1,543 | 53rd |
Industry Pharmaceutical Preparations | 576 out of 1,173 | 51st |
Source: SEC filing on March 28, 2017.
Celano's colleagues
We found three more compensation records of executives who worked with Michael Celano at Recro Pharma in 2016.